POMC - Derived peptides and their biological action

Annals of the New York Academy of Sciences

Volumn 885, Issue , 1999, Pages 22-40

  Solomon, Samuel ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; BETA ENDORPHIN; BETA LIPOTROPIN; CORTICOTROPIN; GAMMA INTERMEDIN; PEPTIDE; PROOPIOMELANOCORTIN;

AMINO TERMINAL SEQUENCE; CONFERENCE PAPER; HUMAN; NONHUMAN; PEPTIDE SYNTHESIS; SKIN FUNCTION; SKIN INJURY;

EID: 0032763135     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08663.x     Document Type: Conference Paper

References (109)

1. 1. Ottaviani, E., A. Franchini & C. Franceschi. 1997. Pro-opiomelanocortin-derived peptides, cytokines and nitric oxide in immune responses and stress: An evolutionary approach. Int. Rev. Cytology 170: 79-141.
2. 2. Castro, M.G. & E. Morison. 1997. Post-translational processing of proopiomelanocortin in the pituitary and in the brain. Crit. Rev. Neurobiol. 11: 35-57.
3. 3. Tatro, J.B. 1996. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. Neuroimmunommodulation 3: 259-284.
4. 4. Luger, T.A., R.S. Bhardivaj, S. Grabbe et al. 1996. Regulation of the immune response by epidermal cytokines and neurohormones. J. Dermatol. Sci. 13: 5-10.
5. 5. Chang, A.C.Y., M. Chochet & S. Cohen. 1980. Structural organization of human genomic DNA encoding pro-opiomelanocortin peptide. Proc. Natl. Acad. Sci. USA 77: 4890-4894.
6. 6. Drouin, J. & H.M. Goodman. 1980. Most of the coding region of rat ACTH, beta-LPH precursor gene lacks intervening sequences. Nature 288: 610-613.
7. 7. Hakanishi, S., Y. Teranishi, Y. Watanabi et al. 1981. Isolation and characterization of the bovine corticotropin/betalipotropin precursor gene. Eur. J. Biochem. 115: 429-434.
8. 8. Harbour-McMenamin, D., E.M. Smith & J.E. Blalock. 1985. Bacterial lipopolysaccharide induction of leukocyte-derived corticotropin and endorphins. Infec. Immunol. 48: 813-817.
9. 9. Harbour, D.V., E.M. Smith & J.E. Blalock. 1987. A novel processing pathway for proopiomelanocortin in lymphocytes: Endotoxin induction of a new prohormone cleaving enzyme. J. Neurosci. Res. 18: 95-101.
10. 10. O'Donohue, T.L. & D.M. Dorsa. 1982. The opiomelanotropinergic neuronal and endocrine system. Peptides (N.Y.) 3: 353-395.
11. 11. Jeannotte, L., J.P.H. Burbach & J. Drouin. 1987. Unusual proopiomelanocortin ribonucleic acids in extra pituitary tissues: intronless transcripts in testes and long poly A tails in hypothalamus. Mol. Endocrinol. 1: 749-757.
12. 12. Schauer, E., F. Trautinger, A. Kock et al. 1994. Proopiomelanocortin derived peptides are synthesized and released by human keratinocytes. J. Clin. Invest. 93: 2258-2262.
13. 13. Lunec, J., J.C. Pieron, G.V. Sherbet et al. 1990. Alpha-melanocortin-stimulating hormone immunoreactivity in melanoma cell. Pathobiol. 58: 193-197.
14. 14. Morhenn, V.B. 1991. The physiology of scratching: Involvement of proopiomelanocortin gene-coded proteins in Langerhans cells. Prog. Neuro. Endo. Immun. 4: 261-265.
15. 15. Farooqui, J.Z., E.E. Medrano, R.E. Boissy et al. 1995. Thy-1 + dendritic cells express a truncated form of POMC mRNA. Exp. Dermatol. 4: 228-232.
16. 16. Slominski, A. 1992. POMC gene expression in hamster and mouse melanoma cells. FEBS Lett. 291: 165-168.
17. 17. Slominski, A., R. Paus & J. Mazurkiewicz. 1992. Proopiomelanocortin expression in the skin during induced hair growth in mice. Experientia 48: 50-54.
18. 18. Slominski, A., R. Paus & J. Wortsman. 1993. On the potential role of proopiomelanocortin in skin physiology and pathology. Molec. Cell Endocrinol. 93: C1-C6.
19. 19. Boston, B.A., K.M. Blaydon, J. Varnerin et al. 1997. Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 278: 1641-1644.
20. 20. Schwartz, M.W., R.J. Seely, S.C. Woods et al. 1997. Leptin increased hypothalamic proopiomelanocortin mRNA expression in rostral arcuate nucleus. Diabetes 46: 2119-2123.
21. 21. Mizuno, T.M., S.P. Kleopoulos, H.T. Bergen et al. 1998. Hypothalamic proopiomelanocortin mRNA is reduced by fasting and (corrected) in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47: 294-297.
22. 22. Cheung, C.C., D.K. Clifton & R.A. Steiner. 1997. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138: 4489-4492.
23. 23. Thorton, J.E., C.C. Cheung, D.K. Clifton et al. 1997. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138: 5063-5066.
24. 24. Sahu, A. 1998. Evidence suggesting that galanin (GAL), melanin-concentrating hormone (MCH) neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y(NPY) are targest of leptin signalling in the hypothalamus. Endocrinology 139: 795-798.
25. 25. Mayan, H., K.T. Ling, E.Y. Lee et al. 1996. Dietary sodium intake modulates pituitary proopiomelanocortin mRNA abundance. Hypertension 28: 244-249.
26. 26. Lindblad, J.R. & J.L. Roberts. 1988. Regulation of propiomelanocortin gene expression in pituitary. Endocr. Rev. 9: 135-158.
27. 27. Wardlaw, S.L., K.C. McCarthy & I.M. Conwell. 1998. Glucocorticoid regulation of hypothalamic proopiomelanocortin. Neuroendocrinology 67: 51-57.
28. 28. Garcia-Garcia, L., J.A. Fuentes & J. Manzanares. 1997. Differential 5-HT-mediated regulation of sites-induced activation of proopiomelanocortin (POMC) gene expression in the anterior and intermediate lobe of the pituitary in male rats. Brain Res. 772: 115-120.
29. 29. Katahira, M., Y. Iwasaki, Y. Aoki et al. 1998. Cytokine regulation of the rat proopio- melanocortin gene expression in AtT-20 cells. Endocrinology 139: 2414-2422.
30. 30. Lyons, P.D. & J.E. Blalock. 1997. Proopiomelanocortin gene expession and protein processing in rat mononuclear leukocytes. J. Neuroimmunol. 78: 47-56.
31. 31. Aoki, Y., Y. Iwasaki, M. Katahira et al. 1997. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells I: Effects of common secretogogues. Endocrinology 138: 1923-1929.
32. 32. Aoki, Y., Y. Iwasaki, M. Katahira et al. 1997. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells II. Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide. Endocrinology 138: 1930-1934.
33. 33. Wardlaw, S.L., J. Kim & S. Sobieszczyk. 1996. Effect of morphine on proopiomelanocortin gene expression and peptide levels in the hypothalamus. Brain Res. Mol. 41: 140-147.
34. 34. Cheung, S. & R.P. Hammer, JR. 1997. Gonadal steroid hormone regulation of proopio- melanocortin gene expression in neurons that innervate the median eminence of the rat. Neurosci. Lett. 224: 181-184.
35. 2+ entry in lactotrophs and somatotrophs from immature rat pituitary by N-terminal fragments of proopiomelanocortin. J. Neuroendocrinol. 10: 217-229.
36. 36. Tilemans, D., D. Rameckers, M. Andries et al. 1997. Effect of POMC (1-76), its C-terminal fragment gamma 3-MSH and anti-POMC (1-76) antibodies on DNA replication in lactotrophs in aggregate cell cultures of immature rat pituitary. J. Neuroendocrinol. 9: 627-637.
37. 37. Hinuma, S., Y. Habata, R. Fijii et al. 1998. A prolactin-releasing peptide in the brain. Nature 393: 272-276.
38. 38. Chakraborty, A.K., Y. Funasaka, A. Slominski et al. 1996. Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochem. Biophys. Acta 1313: 130-138.
39. 39. Teofoli, P., K. Motoki, T.M. Lotti et al. 1997. Proopiomelanocortin (POMC) gene expression by normal skin and keloid fibroblasts in culture: modulation by cytokines. Exp. Dermatol. 6: 111-115.
40. 40. Wakamatsu, K., A. Graham, D. Cook et al. 1997. Characterization of ACTH peptides in human skin and their activation of melanocortin-1 receptor. Pigment Cell Res. 10: 288-297.
41. 41. Jacobson, L., D. Zurakowski & J.A. Majzoub. 1997. Protein malnutrition increases plasma adrenocorticotropin and anterior pituitary proopiomelanocortin messenger ribonucleic acid in the rat. Endocrinology 138: 1048-1057.
42. 42. Chen, X.W., W.Z. Ying, J.P. Valentin et al. 1997. Mechanism of the natriuretic action of gamma-melanocyte stimulating hormone. Am. J. Physiol. 272: R1946-R1953.
43. 43. Fodor, M., A. Sluiter, A. Frankhuizzen-Sierevogel et al. 1996. Distribution of Lys-gamma 2-melanocyte stimulating hormone (Lys-gamma 2-MSH)-like immunoreactivity in neuronal elements in the brain and peripheral tissues of the rat. Brain Res. 731: 182-189.
44. 44. Quillan, J.M. & W. Sadee. 1997. Dynorphin peptides: antagonists of melanocortin receptors Pharm. Res. 14: 713-719.
45. 45. Caylor, C.C., D. Wu, Y. Soong et al. 1997. Dynorphin A1-13 stimulates ovine fetal pituitary-adrenal function through a novel monopoid mechanism. J. Pharmacol. Exp. Ther. 280: 416-421.
46. 46. Furkert, J., U. Klug, A. Slominski et al. 1997. Identification and measurement of beta-endorphin levels in the skin during induced hair growth in mice. Biochem. Biophys. Acta 1336: 315-322.
47. 47. Sanchez-Franco, F. & L. Cacicedo. 1986. Inhibitory effect of β-endorphin on gonadotropin- releasing hormone and thyrotropin-releasing hormone releasing activity in cultured rat anterior pituitary cells. Horm. Res. 24: 55-61.
48. 48. Kandeel, F.R. & R.S. Swerdloff. 1997. The interaction between beta-endorphin and gonadal steroids in regulation of luteinizing hormone (LH) secretion and sex steroid regulation of LH and proopiomelanocortin peptide secretion by individual pituitary cells. Endocrinology 138: 649-656.
49. 49. Lis, M., J. Julesz, J. Gutkowska et al. 1982. Corticotropin-releasing activity of alfamelanocortin. Science 215: 675-677.
50. 50. Rene, F., D. Monnier, C. Gaiddon et al. 1996. Pituitry adenylate cyclase-aclivating polypeptide transduces through cAMP/PKA and PKC pathways and stimulates proopiomelanocortin gene transcription in mouse melanotropes. Neuroendocrinol. 64: 2-13.
51. 51. Ghanem, G., B. Loir, M. Hadley et al. 1992. Partial characterization of IR-alpha-MSH peptides found in melanoma tumors. Peptides 13: 989-994.
52. 52. Luniec, J., C. Pieron, G.V. Sherbet et al. 1990. Alpha-melanocyte-stimulating hormone immunoreactivity in melanoma cells. Pathobiol. 58: 193-197.
53. 53. Hedley, S.J., D.J. Gawkrodger, A.P. Weetman et al. 1998. Alpha-melanocyte stimulating hormone inhibits tumor necrosis factor-alpha stimulated intercellular adhesion molecule-1 expression in normal cutaneous human melanocytes and in melanoma cell lines. Br. J. Dermatol. 138: 536-543.
54. 54. Morandini, R., J.M. Boeymaems, S.J. Hedley et al. 1998. Modulation of ICAM-1 expression by α-MSH in human melanoma cells and melanocytes. J. Cell Physiol. 175: 276-282.
55. 55. Murata, J., K. Ayukawa, M. Ogasawara et al. 1997. Alpha-melanocyte stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells. Invasion Metastasis 17: 89-93.
56. 56. Joosten, E.A., S. Verhoogh, D. Martin et al. 1996. Alpha-MSH stimulates neurite outgrowth of neonatal rat corticospinal neurons in vitro. Brain Res. 736: 91-98.
57. 57. Owen, D.B., J.S. Morley, D.M. Ensor et al. 1997. Trophic effects of melanocortinpotentiating factor (MPF) on cultures of cells of the central nervous system. Peptides 18: 1015-1021.
58. 58. Gonzalez, M.I., V. Kalea, D.R. Hole et al. 1997. Alpha-melanocyte-stimulating hormone (α-MSH) and melanin-concentrating hormone (MCH) modify monoaminergic levels in the preoptic area of the rat. Peptides 18: 387-392.
59. 59. Rajora, N., G. Boecoli, D. Burns, et al. 1997. Alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation. J. Neurosci. 17: 2181-2186.
60. 60. Wong, K.Y., N. Rajora, G. Boecoli et al. 1997. A potential mechanism of local anti-inflammatory action of alpha-melanocyte-stimulating hormone within the brain: modulation of tumor necrosis factor-alpha production by human astrocytic cells. Neuroimmunomodulation 4: 37-41.
61. 61. Tatro, J.B., M.L. Entwistle, B.R. Lester et al. 1990. Melanotropin receptors of murine melanoma characterized in cultured cells and demonstrated in experimental tumors in situ. Cancer Res. 50: 1237-1242.
62. 62. Tatro, J.B., M. Atkins, J.W. Mier et al. 1990. Melanotropin receptors demonstrated in situ in human melanoma. J. Clin. Invest. 85: 1825-1832.
63. 63. Tatro, J.B., Z. Wen, M.L. Entwistle et al. 1992. Interaction of an alpha-melanocyte- stimulating hormone-diphtheria toxin fusion protein with melanotropin receptors in human melanoma metastases. Cancer Res. 52: 2545-2548.
64. 64. Sharma, S.D., M.E. Granberry, J. Jiang et al. 1994. Multivalent melanotropic peptide and fluorescent macromolecular conjugates: new reagents for characterization of melanotropin receptors. Bioconjug. Chem. 5: 591-601.
65. 65. Sharma, S.D., J. Jiang, M.E. Hadley et al. 1996. Melanotropic peptide-conjugated beads for microscopic and visualization and characterization of melanoma melanotropin receptors. Proc. Natl. Acad. Sci. USA 93: 13715-13720.
66. 66. Jiang, J., S.D. Sharma, J.L. Fink et al. 1996. Melanotropic peptide receptors: membrane markers of human melanoma cells. Exp. Dermatol. 5: 325-333.
67. 67. Schioth, H.B., R. Muceniece, M. Larsson et al. 1997. The melanocortin 1,3,4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of α-MSH. J. Endocrinol. 155: 73-78.
68. 68. Schioth, H.B., S. Petersson, R. Muceniece et al. 1997. Deletions of the N-terminal regions of the human melanocortin receoptors. FEBS Lett 410: 223-228.
69. 69. Peng, P.J., V.G. Sahm, R.V. Doherty et al. 1997. Binding and biological activity of C-terminally modified melanocortin peptides: a comparison between their actions at rodent MC1 and MC3 receptors. Peptides 18: 1001-1008.
70. 70. Frandberg, P.A., X. Xu & V. Chhajlani. 1997. Glutamine 235 and arginine 272 in human melanocortin 5 receptor determines its low affinity for MSH. Biochem. Biophys. Res. Commun. 236: 489-492.
71. 71. Yang, Y.K., C. Dickinson, C. Haskell-Luevano et al. 1997. Molecular bases for the interaction of [Nle4,0-Phe 1] melanocyte stimulating hormone with the human melanocortin-1 receptor. J. Biol. Chem. 272: 23000-23010.
72. 72. Schioth, H.B., R. Mucenieci, J.E. Wikberg et al. 1996. Alternative translation initiation codon for the human melanocortin MC3 receptor does not affect the ligand binding. Eur. J. Pharmacol. 314: 381-384.
73. 73. Schioth, H.B., R. Muceniece & J.E. Wikberg. 1996. Characterization of the melanocortin 4 receptor by radioligand binding. Pharmacol. Toxicol. 79: 161-165.
74. 74. Schioth, H.B., R. Muceniece & J.E. Wikberg. 1997. Selectivity of [Phe-17], [A1 6], and [D-ala 4, Glu 5, Tyr 6] substituted ACTH (4-10) analogues for the melanocortin receptors. Peptides 18: 761-763.
75. 75. Bugg, J.J. 1998. Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on β-lymophocytes activates the Jak/STAT pathway. Biochem. J. 331: 211-216.
76. 76. Kask, A., L. Rago, F. Mutulis et al. 1998. Selective antagonist for melanocortin 4 receptor (HS 014) increases food intake in free-feeding rats. Biochem. Biophys. Res. Commun. 245: 90-93.
77. 77. Kistler-Heer, V., M.E. Lauber & W. Lichtensteiger. 1998. Different development patterns of melanocortin MC3 and MC4 receptor mRNA: predominance of MC4 in fetal rat nervous system. J. Neuroendocrinol. 10: 133-146.
78. 78. Van Der Kraan, M., R.A. Adan, M.L. Entwistle et al. 1998. Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. Endocrinology 139: 2348-2355.
79. 79. Zheng, T., C. Villalobos, K.D. Nusser et al. 1997. Phenotypic characterization and functional correlation of alpha-MSH binding to pituitary cells. Am. J. Physiol. 272: E282-E287.
80. 80. Malmed, S. 1998. gp 130-related cytokines and their receptors in the pituitary. Trends Endocrinol. Metab. 9: 155-161.
81. 81. Mastorakos, G., J.S. Weber & M.-A. Magiakou. 1994. Hypothalamic-pituitary adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implication for the syndrome of inappropriate vasopressin secretion. J. Clin. Endocrinol. Metab. 79: 934-939.
82. 82. Patterson, P.H. 1994. LIF, a cytokine at the interface between neurology and immunology. Proc. Natl. Acad. Sci. USA 91: 7833-7835.
83. 83. Akita, S., J. Webster, S.O. Ren et al. 1995. Human and murine pituitary expression of leukemia inhibitory factor-novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J. Clin. Invest. 95: 1288-1298.
84. 84. Wang, Z., S.G. Ren & S. Melmed. 1996. Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. Endocrinology 137: 2947-2953.
85. 85. Shimon, I., X. Yan, D.W. Ray et al. 1996. Cytokine-dependent gp 130 receptor sub-unit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. J. Clin. Invest. 100: 357-363.
86. 86. Ray, D., S.G. Ren & S. Melmed. 1996. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line: role of stat pathway. J. Clin. Invest. 97: 1852-1859.
87. 87. Bousquet, C., D. Ray & S. Melmed. 1997. A common proopiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy. J. Biol. Chem. 272: 10551-10557.
88. 88. Bultman, S.J., E.J. Michaud & R.P. Woychik. 1992. Molecular characterization of the mouse agouti locus. Cell 71: 1195-1204.
89. 89. Muller, M.W., D.M.J. Duhl, H. Vrieling et al. 1993. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Gene Dev. 7: 454-467.
90. 90. Wilson, D.B., M.M. Ollmann, L. Kang et al. 1994. Structure and function of ASP, the human homology of the mouse agouti gene. Hum. Mol. Genet. 4: 223-230.
91. 91. Willard, D.H., W. Bodnar, C. Harris et al. 1995. Agouti structure and function: Characterization of the potent α-melanocyte stimulating hormone receptor antagonist. Biochem. 34: 12341-12346.
92. 92. Blanchard, S.G., C.O. Harris, O.R.R. Ittoop et al. 1995. Agouti antagonism of melanocortin-binding and action in the B16F10 murine melanoma cell line. Biochem. 34: 10496-10411.
93. 93. Lu, D., D. Willard, I.R. Patel et al. 1994. Agouti protein is an antagonist of the melano- cyte-stimulating-hormone receptor. Nature 371: 799-804.
94. vy/- mice. Ectopic expression of the agouti gene. FASEB J. 8: 479-488.
95. 95. Furumura, M., C. Sakai, Z. Abdel-Malek et al. 1996. The interaction of agouti signal protein and melanocyte stimulating hormone to regulate melanin formation in mammals. Pigment Cell Res. 9: 191-203.
96. 96. Graham, A., K. Wakemutsu, G. Hunt et al. 1997. Agouti protein inhibits the production of eumelanin and phaeomelanin in the presence and absence of alpha-melanocyte stimulating hormone. Pigment Cell Res. 10: 298-303.
97. 97. Fan, W., B.A. Boston, R.A. Kesterson et al. 1997. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385: 165-168.
98. 98. Huszar, D., C.A. Lynch, V. Fairchild-Huntress et al. 1997. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141.
99. 99. Ollmann, M.M., B.D. Wilson, Y.K. Yang et al. 1997. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278: 135-138.
100. 100. Fong, T.M., C. Mao, T. MacNeil et al. 1997. ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem. Biophys. Acta 237: 629-631.
101. 101. Suzuki, I., A. Tada, M.M. Ollmann et al. 1997. Agouti signalling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin. J. Invest. Dermatol. 108: 838-842.
102. 102. Kesterson, R.A., D. Huszar, C.A. Lynch et al. 1997. Induction of neuropeptide Y gene expression is the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol. Endocrinol. 11: 630-637.
103. 103. Ollmann, M.M., M.L. Lamoreux, B.D. Wilson et al. 1998. Interaction of agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes Dev. 12: 316-330.
104. 104. Kim, J.H., L.L. Kiefer, R.P. Woychek et al. 1997. Agouti regulation of intracellular calcium: role of melanocortin receptors. Am. J. Physiol. 272: E379-E384.
105. 105. Kiefer, L.L., J.M. Veal, K.G. Mountjoy et al. 1998. Melanocortin receptor binding determinants in the agouti protein. Biochem. 37: 991-997.
106. 106. David, G., V. Lories, B. Decock et al. 1990. Molecular cloning of a phosphatidyl inositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblast. J. Cell Biol. 111: 3165-3176.
107. 107. Gallo, R.L., M. Ono, T. Poosic et al. 1994. Syndecons, cell surface heparin sufate proteoglycans, are induce by a proline-rich antimicrobial peptide from wounds. Proc. Natl. Acad. Sci. USA 91: 11035-11039.
108. 108. Agerberth, B., J.Y. Lee, T. Bergman et al. 1991. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine rich antibacterial peptides. Eur. J. Biochem. 202: 849-854.
109. 109. Frohm, M., B. Agerberth, G. Ahangari et al. 1996. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272: 15258-15263.